|
David Singer joined Maverick in 2004 from Oscient Pharmaceutical Corporation, where he also serves as Chairman of the Board. Prior to Oscient, Mr. Singer was the founder and former CEO of three pioneering biotech companies: Affymetrix, Inc., Corcept Therapeutics, Inc., and Genesoft Pharmaceuticals. Mr. Singer curently serves on the board of both Affymetrix and Corcept. Before these experiences, Mr. Singer was the senior financial officer at Heartport and Affymax. He began his career at Baxter International and worked at Goldman Sachs & Co. Mr. Singer received his B.A. from Yale University and his M.B.A. from Stanford University. He is a Crown Fellow of the Aspen Institute, and a Sterling Fellow of Yale University. | 